Overview
Spondyloarthritis caused by parasitic infections in dogs is a less commonly discussed condition, often overshadowed by other forms of spondyloarthritis. The importation of dogs from overseas increases the risk of parasitic transmission, necessitating thorough parasite control measures 1.Diagnosis
Clinical signs may include musculoskeletal pain, stiffness, and reduced mobility.
Diagnostic imaging (e.g., radiography, MRI) can reveal characteristic changes in the spine and sacroiliac joints.
Serological tests and parasitological examinations (e.g., fecal analysis) to identify specific parasites.
Histopathological examination of affected tissues may be necessary for definitive diagnosis 1.Management
First-line treatments: Antiparasitic drugs targeting the specific identified parasite (e.g., fluralaner for ectoparasites).
- Fluralaner: Administer at recommended doses; however, specific dosing for spondyloarthritis due to parasites is not detailed 2.
Adjunctive therapies: Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation management.
Supportive care: Physical therapy and weight management to alleviate symptoms and improve mobility 1.Special Populations
Pregnancy: Limited data; consult parasitology guidelines for safe antiparasitic use during gestation 1.
Pediatrics: Tailored dosing based on weight and specific parasite identified; consult veterinary guidance 2.
Elderly: Consider increased susceptibility to complications; monitor closely for adverse reactions to treatments 1.
Comorbidities: Adjust treatment plans to avoid interactions with existing conditions; close monitoring essential 1.Key Recommendations
Conduct thorough parasite screening for imported dogs to prevent spondyloarthritis transmission (Evidence: Expert opinion 1).
Use appropriate antiparasitic therapy based on identified parasites, considering dose adjustments for special populations (Evidence: Moderate 2).
Incorporate adjunctive NSAID therapy for symptomatic relief, alongside supportive care measures (Evidence: Expert opinion 1).References
1 . Importing a problem. The Veterinary record 2021. link
2 Walther FM, Allan MJ, Roepke RK, Nuernberger MC. Safety of fluralaner chewable tablets (Bravecto), a novel systemic antiparasitic drug, in dogs after oral administration. Parasites & vectors 2014. link